Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoidosis | 1 | 2014 | 33 | 0.400 |
Why?
|
| Early Diagnosis | 1 | 2014 | 99 | 0.400 |
Why?
|
| Multimodal Imaging | 1 | 2014 | 71 | 0.400 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 130 | 0.370 |
Why?
|
| Coffee | 1 | 2009 | 18 | 0.310 |
Why?
|
| Infarction | 1 | 2007 | 20 | 0.260 |
Why?
|
| Heart Failure | 2 | 2011 | 926 | 0.220 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2025 | 43 | 0.220 |
Why?
|
| Hospitalization | 2 | 2011 | 1368 | 0.200 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 747 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 628 | 0.180 |
Why?
|
| Brachial Artery | 1 | 2014 | 28 | 0.110 |
Why?
|
| Vasodilation | 1 | 2014 | 36 | 0.100 |
Why?
|
| Sweden | 2 | 2011 | 59 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2014 | 176 | 0.100 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2014 | 109 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 220 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2014 | 156 | 0.090 |
Why?
|
| Incidence | 3 | 2011 | 1383 | 0.090 |
Why?
|
| Coffea | 1 | 2011 | 2 | 0.090 |
Why?
|
| Drinking Behavior | 1 | 2011 | 9 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 984 | 0.080 |
Why?
|
| Echocardiography | 1 | 2014 | 509 | 0.080 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 2478 | 0.080 |
Why?
|
| Survival Rate | 2 | 2009 | 859 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 249 | 0.070 |
Why?
|
| Cause of Death | 1 | 2009 | 222 | 0.070 |
Why?
|
| Biomarkers | 1 | 2014 | 1431 | 0.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 143 | 0.070 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2009 | 66 | 0.070 |
Why?
|
| Prognosis | 2 | 2009 | 1769 | 0.070 |
Why?
|
| Inflammation | 1 | 2014 | 1162 | 0.070 |
Why?
|
| Cardiac Catheterization | 1 | 2009 | 292 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2007 | 167 | 0.060 |
Why?
|
| Cushing Syndrome | 1 | 2025 | 10 | 0.060 |
Why?
|
| Aortic Coarctation | 1 | 2025 | 11 | 0.060 |
Why?
|
| Hyperaldosteronism | 1 | 2025 | 9 | 0.060 |
Why?
|
| Humans | 8 | 2025 | 64238 | 0.060 |
Why?
|
| Renal Artery Obstruction | 1 | 2025 | 22 | 0.060 |
Why?
|
| Thyroid Diseases | 1 | 2025 | 30 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2011 | 3315 | 0.060 |
Why?
|
| Pheochromocytoma | 1 | 2025 | 31 | 0.060 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2025 | 47 | 0.060 |
Why?
|
| Male | 5 | 2014 | 30294 | 0.060 |
Why?
|
| Time Factors | 2 | 2009 | 3724 | 0.060 |
Why?
|
| Registries | 1 | 2009 | 885 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2025 | 61 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2025 | 172 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2007 | 554 | 0.050 |
Why?
|
| Aged | 5 | 2014 | 14648 | 0.050 |
Why?
|
| Adult | 2 | 2014 | 17116 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2025 | 147 | 0.050 |
Why?
|
| Female | 6 | 2025 | 33350 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 2737 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 915 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 1669 | 0.040 |
Why?
|
| Risk Factors | 1 | 2009 | 5339 | 0.040 |
Why?
|
| Middle Aged | 3 | 2014 | 17898 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 2370 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2007 | 2217 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2014 | 6726 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 166 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 5520 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 486 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 944 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1407 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 735 | 0.020 |
Why?
|
| Rhode Island | 1 | 2009 | 104 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2009 | 285 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2009 | 330 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 271 | 0.020 |
Why?
|
| Shock, Cardiogenic | 1 | 2007 | 104 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1561 | 0.010 |
Why?
|
| United States | 1 | 2014 | 7923 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 5691 | 0.010 |
Why?
|